Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 20, 2013International Journal of OncologyOpen Access

Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle

View Full Paper
Ask AI
Bookmark
Share

Authors

JGJaromír GumulecJBJan BalvanMSMarkéta Sztalmachová

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gumulec et al. (2013) studied this question.

synapsesocial.com/papers/6aaba0c495b10025d1a8b7bchttps://doi.org/10.3892/ijo.2013.2223
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cisplatin-Induced Chemoresistance in Colon Cancer Cells Involves FXR-Dependent and FXR-Independent Up-Regulation of ABC Proteins2012 · 67 citations
  2. 2Biochemical Modulation of Cisplatin Mechanisms of Action:  Enhancement of Antitumor Activity and Circumvention of Drug Resistance2003 · 889 citations
  3. 3Chemotherapeutic Sensitivity of Testicular Germ Cell Tumors Under Hypoxic Conditions Is Negatively Regulated by SENP1-Controlled Sumoylation of OCT42012 · 53 citations
  4. 4Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells2012 · 58 citations